|
|
|
|
|
SIZE:
|
|
|
|
GENERIC NAME:
|
|
|
|
MANUFACTURER:
|
|
|
|
UNIT:
|
|
|
|
ADMINISTRATION ROUTE:
|
|
|
|
FDA PREGNANCY GROUP:
|
|
(none)
|
|
INDICATIONS:
|
|
Arthritis, osteoarthritis |
| |
|
|
SIDE EFFECTS:
|
|
Allergic reaction |
|
anaphylactoid reaction |
|
Ecchymosis |
|
gastrointestinal effects |
|
headache |
|
inflammation of the knee |
|
pain at the injection site |
|
pruritus |
|
|
ABSOLUTE
CONTRAINDICATIONS :
|
|
|
|
RELATIVE
CONTRAINDICATIONS : |
|
|
|
ADULT DOSE:
|
|
Pain-
Intra-articular, 20 mg once a week for a total of five injections.
Note: Injections should be given one week apart .
Efficacy for the use of less than five injections has not been established . |
|
MAXIMUM ADULT DOSE:
|
|
20 mg once a week for a total of five injections .
Note: Safety and efficacy for repeat treatment cycles have not been established .
|
|
PEDIATRIC DOSE:
|
|
Safety and efficacy have not been established .
|
|
MAXIMUM PEDIATRIC
DOSE:
|
|
|
|
ELDERLY DOSE:
|
|
Pain-
Intra-articular, 20 mg once a week for a total of five injections.
Note: Injections should be given one week apart .
Efficacy for the use of less than five injections has not been established . |
|
|
|
|